Specific detection of EGF-EGFR complexes on the cell surface and their dependency on EGFR-directed TKI treatment
Open Access
- 18 December 2025
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 800, 153165
Abstract
No abstract availableKeywords
Funding Information
- Christian Doppler Forschungsgesellschaft
- Österreichische Nationalstiftung für Forschung, Technologie und Entwicklung
- Austrian Science Fund (W1224)
This publication has 40 references indexed in Scilit:
- Phase I clinical trial of EGFR-specific CAR-T cells generated by the piggyBac transposon system in advanced relapsed/refractory non-small cell lung cancer patientsJournal of Cancer Research and Clinical Oncology, 2021
- Clathrin‐mediated EGFR endocytosis as a potential therapeutic strategy for overcoming primary resistance of EGFR TKI in wild‐type EGFR non‐small cell lung cancerCancer Medicine, 2020
- Emerging functions of the EGFR in cancerMolecular Oncology, 2017
- Clinical Pharmacokinetics and Pharmacodynamics of AfatinibClinical Pharmacokinetics, 2016
- Chimeric antigen receptor-modified T cells for the immunotherapy of patients with EGFR-expressing advanced relapsed/refractory non-small cell lung cancerScience China Life Sciences, 2016
- Methods to study endocytic trafficking of the EGF receptor2015
- The Somatic Genomic Landscape of GlioblastomaCell, 2013
- Structural basis for inhibition of the epidermal growth factor receptor by cetuximabCancer Cell, 2005
- Epidermal growth factor in human breast cancer, endometrial carcinoma and lung cancer. Its relationship to epidermal growth factor receptor, estradiol receptor and tumor TNMClinica Chimica Acta, 1993
- Quantification of epidermal growth factor in human breast cyst fluids: Correlation with dehydroepiandrosterone‐sulphate and electrolyte concentrationsInternational Journal of Cancer, 1989